


Rapid Detection of Hemoglobins A, S, and C
in Just a Droplet of Blood.
-
Five Quick Steps
-
10 Minutes
-
Highly Accurate Results


Accurate Results on-the-Spot
No Liquid
Buffers
Required

No Electricity
Required


Room
Temperature
Storage

2-Year
Shelf Life

Dried Blood Spot-Compatible
HOW IT WORKS
STEP 1
Using Dropper Pipette, add six (6) drops of water to Test Vial. Place Test Vial in a compatible rack. 1.5-mL test tubes may also be used.
STEP 2
Obtain blood sample – a small drop is sufficient (about one microliter). Touch the white pad below the blue cover of the Blood Sampling Device to blood sample, until the white pad absorbs blood droplet


STEP 3
Insert Blood Sampling Device into Test Vial and swirl to mix.
A. Sufficient swirling is essential for blood to be properly transferred into Test Vial.
B. Check visually to ensure that water has become pink or light-red in color.
C. Leave Blood Sampling Device inside the Test Vial water after swirling.

STEP 4
Insert HemoTypeSC™ Test Strip into Test Vial with arrows pointing DOWN.
STEP 5
Wait 10 minutes.
STEP 6
Take HemoTypeSC™ Test Strip out of the Test Vial and read results.



INSTRUCTIONAL VIDEO
SUCCESS STORIES
GLOBAL REGISTRATIONS

European
Union

Kenya

Saudi Arabia

Nigeria

Tanzania

Togo

India

Côte d'Ivoire

Ghana

Sierra Leone

POC Testing for SCD Added to 2021 WHO EDL
PEER-REVIEWED PUBLICATIONS
IN THE NEWS
New Sickle Cell Disease Testing on Nigerian Newborns
A newly released study seeks to increase sickle cell disease detection and treatment rates in newborn babies across Nigeria through HemoTypeSC, a rapid diagnostic test.
$2 Test Could Transform Sickle Cell Dx in Africa
An inexpensive, easy-to-use blood test could dramatically alter how sickle cell disease is diagnosed in Africa, where the often-undiagnosed disease is a leading cause of childhood mortality.
Advocacy for the Construction of a Sickle Cell Anemia Care Center in Côte d'Ivoire
Patrice Sékongo, country director of the European Institute for Cooperation and Development, called for mass screening and improved patient care thanks to a preventive system that is operational. In a presentation on the evolution of screening tools, Dr Yao Atimeré, a hematologist, presented the HemoTypeSC test, which can detect sickle cell anemia in ten minutes. A solution that comes to save lives.
Lack of Funds Hinders Govt’s Policy on SCD
Speaking at the presentation of HemoTypeSC, a care test for the detection of SCD, Dr. Alayo Sopekan, National Desk Officer on Sickle cell, Ministry of Health, [noted] that the country has put in place a policy to address the disease, such as testing for newborn, Sopekan, however, said the lack of fund has not allowed for the implementation.
A 10-minute Test Could Solve Africa’s Sickle Cell Disease Screening Problem for Newborns
A $2, 10-minute rapid point-of-care tool has brought the much elusive goal of rapidly screening Africa’s newborns for sickle cell disease (SCD), a major cause of child mortality, within reach.
New Sickle Cell Test Can Transform Screening
A new test that costs less than $2, requires only a small drop of blood, and can be performed in about 10 minutes could dramatically change the dynamics of sickle cell diagnosis in Africa.

Fraternité Matin
In Print
Good News for Ivorian People. Now, They Can Know Their Hemoglobin Status Thanks to the HemoTypeSC Test...
Eugène Aka-Aouélé, Minister of Health and Dr. ADOUENI Katché Valéry, Coordinating Director of the National Program for Metabolic Diseases and NCD Prevention, have stated that the [HemoTypeSC test] will enable Ivory Coast to take a step forward in the fight against sickle cell disease.
Experts Advocate Newborn Screening for Sickle Cell Disease
Professor Obiageli Nnodu, sickle cell disease expert from the University of Abuja, describes the current status of sickle cell disease in Nigeria and the results from early testing with HemoTypeSC™.
Rapid Result Test On Track to Transform Sickle Cell Disease Screening for Millions
Now, research shows that with a new rapid result test kit, a diagnosis of sickle cell disease may no longer be a death sentence for children in the most affected parts of the world...The test has the potential to be a game-changer for people with the disease who live in distressed areas around the world.
New Tools and Approaches Poised to Improve Diagnostics and Care for Millions Worldwide
A trial in Uganda showed a new test called HemoTypeSC was more than 99 percent accurate in detecting sickle cell disease in young children. The test requires only a small drop of blood and returns results in about 10 minutes, making it suitable for routine screening of newborns.
Television News Coverage of Accuracy+Feasibility Validation Study Workshop - Côte d'Ivoire